Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice
Author(s) -
Kota Suzuki,
Kimio Satoh,
Shohei Ikeda,
Shinichiro Sunamura,
Tomohiro Otsuki,
Taijyu Satoh,
Nobuhiro Kikuchi,
Junichi Omura,
Ryo Kurosawa,
Masamichi Nogi,
Kazuhiko Numano,
Koichiro Sugimura,
Tatsuo Aoki,
Shunsuke Tatebe,
Satoshi Miyata,
Rupak Mukherjee,
Francis G. Spinale,
Kenji Kadomatsu,
Hiroaki Shimokawa
Publication year - 2016
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.115.306686
Subject(s) - cardiac fibrosis , fibrosis , pressure overload , heart failure , medicine , muscle hypertrophy , basigin , endocrinology , ventricular remodeling , inflammation , matrix metalloproteinase , cardiac hypertrophy
Basigin (Bsg) is a transmembrane glycoprotein that activates matrix metalloproteinases and promotes inflammation. However, the role of Bsg in the pathogenesis of cardiac hypertrophy and failure remains to be elucidated. We examined the role of Bsg in cardiac hypertrophy and failure in mice and humans.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom